We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Biosimilars Makers Seek More Appropriate Labeling Format
European Biosimilars Makers Seek More Appropriate Labeling Format
Europe’s biotech industry is pressing regulators to update guidance on labeling of biosimilars to include information on both the reference product and the biosimilar. The current practice of assigning a generic label is insufficient due to the products’ unique scientific and regulatory status, companies say.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor